AlbertM.BernathJr.MD

Oncology • Danville, PA

Physician

Join to view full profile

Are you Dr. Bernath?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
100 N Academy Ave
Danville, PA 17822
Phone+1 570-271-6045

Fax+1 570-271-6542

Summary

Dr. Albert Bernath Jr., MD is an oncologist in Danville, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Geisinger Medical Center.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1976
Duke University HospitalResidency, Internal Medicine, 1972 - 1974
University of Pittsburgh School of MedicineClass of 1972

Certifications & Licensure

PA State Medical License 1976 - 2014

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
Completed
Phase 1, Phase 2
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2006 Feb 01
Completed
Phase 2
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
Completed
Phase 3
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2006 Mar 24
Completed
Phase 1, Phase 2
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
Completed
Phase 2
Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Start of enrollment: 2007 Sep 01
Completed
Phase 3
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy Start of enrollment: 2008 Jun 15
Completed
Phase 3
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Acute Pain Caused by Paclitaxel in Patients With Cancer Start of enrollment: 2009 Feb 01
Completed
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Home-Based Programs for Improving Sleep in Cancer Survivors Start of enrollment: 2010 Apr 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

11 citations
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Can...
Patrick A. Burch, Chirantan Ghosh, Georgene Schroeder, Cristine Allmer, Charles L. Woodhouse
American Journal of Clinical Oncology. 2000-10-01
71 citations
Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment
Robert A. Schnoll, Elisa Martinez, Kristina L. Tatum, Marcella Glass, Albert M. Bernath
Addictive Behaviors. 2011-01-01
61 citations
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Ivana T. Croghan, Richard D. Hurt, Shaker R. Dakhil, Gary A. Croghan, Jeff A. Sloan
Mayo Clinic Proceedings. 2007-02-01

Grant Support

Geisinger Clinical Oncology ProgramNational Cancer Institute1990–2010
Geisinger Clinical Oncology ProgramNational Cancer Institute1987–2007
Community Clinical Oncology ProgramNational Cancer Institute1985–1986